Camp4 Therapeutics (CAMP) Interest Coverage Ratio (2023 - 2026)
Camp4 Therapeutics (CAMP) reported Interest Coverage Ratio of 233.41 for Q1 2026, down 1924.08% on a YoY basis from 12.8 in Q1 2025, and down 1500.41% sequentially from 14.58 in Q4 2025.
Camp4 Therapeutics (CAMP) Interest Coverage Ratio (2023 - 2026) Analysis & Trends
Camp4 Therapeutics (CAMP) has 4 years of Interest Coverage Ratio data on file, last reported at 233.41 in Q1 2026.
- For the quarter ending Q1 2026, Interest Coverage Ratio fell 1924.08% year-over-year to 233.41; the trailing twelve-month figure through Mar 2026 stood at 17.84 (down 25.7% YoY), and the FY2025 full-year result was 0.69, up 15.59% from the prior year.
- Interest Coverage Ratio slipped to 233.41 in Q1 2026, from 14.58 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 1.31 in Q3 2024 to a low of 233.41 in Q1 2026.
- A 4-year average of 33.71 and a median of 15.58 in 2025 frame the typical range for Interest Coverage Ratio.
- Across the five-year window, Interest Coverage Ratio soared 92.01% in 2024 and tumbled 1924.08% in 2026, its largest moves.
- Tracing CAMP's Interest Coverage Ratio over 4 years: stood at 29.04 in 2023, then surged by 44.27% to 16.19 in 2024, then advanced by 9.9% to 14.58 in 2025, then tumbled by 1500.41% to 233.41 in 2026.
- Business Quant data shows CAMP's Interest Coverage Ratio at 233.41 in Q1 2026, 14.58 in Q4 2025, and 15.58 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Camp4 Therapeutics | 174.35 Mn | 174.35 Mn | - | -233.41 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -233.41 |
| Dec 31, 2025 | -14.58 |
| Sep 30, 2025 | -15.58 |
| Jun 30, 2025 | -1.72 |
| Mar 31, 2025 | -11.53 |
| Dec 31, 2024 | -16.19 |
| Sep 30, 2024 | -1.31 |
| Jun 30, 2024 | -19.48 |
| Mar 31, 2024 | -11.67 |
| Dec 31, 2023 | -29.04 |
| Sep 30, 2023 | -16.34 |